This is the first study I've seen testing metformin in an orthotopic glioma model with oral (rather than intraperitoneal) administration. The survival gain was modest, but threre was a gain nonetheless.
http://exp-oncology.com.ua/wp/wp-content/uploads/2017/12/2419.pdf?upload= (see figure 4)
No comments:
Post a Comment